• Western blot analysis of the lysates from HUVECcells using GLRB antibody.
  • Western blot analysis of GLRB Antibody. The lane on the right is blocked with the GLRB peptide.

Anti-GLRB antibody (211-260 aa) (STJ93300)

SKU:
STJ93300

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Glycine receptor subunit beta (211-260 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:40000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: GLRB
Gene ID: 2743
Uniprot ID: GLRB_HUMAN
Immunogen Region: 211-260 aa
Specificity: GlyR Beta Polyclonal Antibody detects endogenous levels of GlyR Beta protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human GLRB at the amino acid range 211-260
Protein Name Glycine Receptor Subunit Beta
Glycine Receptor 58 Kda Subunit
Database Links Reactome: R-HSA-112314
Cellular Localisation Postsynaptic Cell Membrane
Multi-Pass Membrane Protein
Synapse
Cell Projection
Dendrite
Cell Membrane
Cytoplasm
Retained In The Cytoplasm Upon Heterologous Expression By Itself
Coexpression With Gphn Promotes Expression At The Cell Membrane
Coexpression With Glra1
Glra2 Or Glra3 Promotes Expression At The Cell Membrane
Alternative Antibody Names Anti-Glycine Receptor Subunit Beta antibody
Anti-Glycine Receptor 58 Kda Subunit antibody
Anti-GLRB antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance